Loxo Oncology (LOXO) Reports Q3 Loss of $2.26/Share

Loxo Oncology (NASDAQ: LOXO) reported Q3 EPS of ($2.26), versus ($0.94) reported last year. Revenue for the quarter came in at $42.5 million, versus $0 reported last year.

For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04